ORTHOWORLD Inc.的动态

A recent article from ORTHOWORLD Inc. highlights the surge in mergers and acquisitions focused on #digital assets in the orthopedic space. Companies are increasingly recognizing the value of integrating digital technologies into their offerings. As per the article, transactions for technology assets account for ????% ???? ?????? ?????????? ???????? ???? ?????? ?????? ???? ??????????????????. As we move forward as an industry, integrating digital solutions will help ?????????? ????????????????????, ?????????????? ????????????????????????, ???????????????????? ????????????????????, ?????? ?????????????? ?????????????? ????????. At Enhatch, we’re proud to be part of this evolution, offering digital 3D planning solutions that streamline the preoperative planning process for patient-specific solutions. We can help medical device companies, distributors, and point-of-care facilities ???????????? ?????????? ?????? ???????????????? ???? ??????????????-???????????????? ??????????????????. #3Dplanning #medtech #preoperativeplanning #orthopedics #meddev #PointOfCare #distributors https://lnkd.in/e9m4n-G8

M&A deals are at a?decade-low level across medtech. Only six orthopedic acquisitions have been announced this year, far fewer than the nearly 30 deals completed in 2023. Still, noteworthy transactions have taken place. Stryker, Enovis and Smith+Nephew are among the most active companies in M&A activity. Their efforts to expand product offerings are worth noting in a landscape that’s expected to remain relatively quiet into 2025: https://lnkd.in/e6rqcVjk #orthopedics #spine #sportsmedicine #jointreplacement #trauma #marketintelligence #MergerandAcquisition #MandA #businessgrowth

M&As (+divestures), and subsequent integrations, transfers, harmonization, etc are all, necessary, part of the industry and innovation, yet also a lot of (thank-less) work for people involved. With that said....if you ever been part of M&A, you know it is exciting, challenging, and growing experience. Hence, I am excited to read that "Orthopedic M&A Activity Beginning to Bounce Back ? " ? Orthopedic M&A?deals accelerated in 2023, according to ORTHOWORLD Inc. reporting. The jump?in activity marks the first year-over-year increase since 2020... Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions: >> Smith+Nephew acquired CartiHeal?last November to capture the company’s novel technology for regenerating cartilage in the knee. >> Enovis acquired LimaCorporate?in January to gain addition tractions in the extremities and reconstruction segments. >> Stryker acquired France-based SERF?in December to add to its hip replacement portfolio across Europe. >> Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it?completed its merger?with NuVasive last September. >> restor3d acquired @Conformis?last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices. Looking forward seeing what 2024 will deliver! #mergersandacquisitions | #integrations

Orthopedic M&A?deals accelerated in 2023, according to ORTHOWORLD Inc. reporting. The jump?in activity marks the first year-over-year increase since 2020, but still fell short of the 42 orthopedic transactions ORTHOWORLD tracked that year. Still, there’s reason for optimism and a livelier M&A market in the years ahead. Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions: Smith & Nephew acquired CartiHeal last November to capture the company’s novel technology for regenerating cartilage in the knee. Enovis acquired Lima Corporate?in January to gain addition tractions in the extremities and reconstruction segments. Stryker acquired France-based SERF in December to add to its hip replacement portfolio across Europe. Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it?completed its merger?with NuVasive last September. restor3d acquired Conformis - acquired by restor3d?last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices. ORTHOWORLD expects?M&A deal volume?to hold steady in 2024 amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market could become more active sometime in 2025 as interest in orthopedic targets remains strong. Read the article here: https://lnkd.in/eUS5ik8C #MedicalDevices #Innovation #Acquisition

ORTHOWORLD Inc. expects?M&A deal volume?to hold steady this year amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market is due for a rebound and could become more active sometime in 2025 as interest in #orthopedic targets remains strong. Check out our latest infographic sponsored by Intech for recent deals that are worth monitoring and a breakdown of the most active players in orthopedics in recent years: https://lnkd.in/eUw_EFUk #orthopedicsurgery #medtech #MandA #marketintelligence

Last month, the Elos Orthopedics team from the US went on a week-long expedition in collaboration with our colleagues at Klingel across Germany and Switzerland - Precisely, Rosenheim, H?lstein, and Matzingen. It was a week of fruitful discussions on how our recent merger will translate into tangible benefits to the orthopedic industry. Here's a glimpse into their experience, as recounted by Tim Turner, VP of Sales and Business Development at our Memphis site: ? "We met a strong team, primed for expansion," Tim reflects. "Each facility exuded capability, with established processes and systems in place, and untapped potential waiting to be unleashed. It's exciting to see the convergence of our visions and values through collaboration, and beyond the metrics, there's a sense of kinship and collective ambition." he adds. ? Throughout the week, conversations revolved around the nuances of collaboration and integration. "We delved into how we can harmonize our efforts," Tim explains. "It's not only about working together; it's about leveraging our respective strengths to propel us forward." ? The integration of Elos Medtech and Klingel operations in orthopedic production paints a compelling picture. "Our processes seamlessly complement each other," Tim notes. "Through integration we're paving the way for holistic solutions that cater to the entire orthopedic manufacturing supply chain." ? This collaboration means more than just operational streamlining; it signifies a strategic repositioning in the market. "With Klingel, we're not just broadening our horizons," Tim stresses. "We're reshaping our collective identity, transitioning from two entities into a unified powerhouse”. Find out more about Elos Orthopedics: https://lnkd.in/ej5WDCZY #ElosMedtech #Klingel #Orthopedics #MedicalDevices #CDMO #ContractManufacturing #Integration

Orthopedics Trend #20: Acceleration of Orthopedic Consolidation In 2023, a select group of 45 orthopedic businesses surpassed the $100 million revenue mark, collectively commanding 84% of the sector's sales. This concentration of market power underscores a clear trend: the industry's leading players are poised to further consolidate their dominance, actively pursuing acquisitions of enabling technologies. The momentum in orthopedic mergers and acquisitions (M&A) notably picked up last year, with the completion of 29 transactions, a significant increase from the 22 recorded the previous year. These deals were particularly concentrated in the areas of spine, orthobiologics, and enabling technologies, indicating strategic areas of focus for growth and expansion in the orthopedic domain. Explore 21 more trends redefining the orthopedics landscape here - https://lnkd.in/efNSUCTi

Orthopedics Trend #20: Acceleration of Orthopedic Consolidation In 2023, a select group of 45 orthopedic businesses surpassed the $100 million revenue mark, collectively commanding 84% of the sector's sales. This concentration of market power underscores a clear trend: the industry's leading players are poised to further consolidate their dominance, actively pursuing acquisitions of enabling technologies. The momentum in orthopedic mergers and acquisitions (M&A) notably picked up last year, with the completion of 29 transactions, a significant increase from the 22 recorded the previous year. These deals were particularly concentrated in the areas of spine, orthobiologics, and enabling technologies, indicating strategic areas of focus for growth and expansion in the orthopedic domain. Explore 21 more trends redefining the orthopedics landscape here - https://lnkd.in/g7cwPJtw

Global #Surgical #Power #Tools Market by Product (Drill, Saw, Reamer, Shaver, Wire Driver, Power Source, and Accessories), Application (Orthopedic, Neuro, Dental, ENT, and Cardiothoracic), Usage (Reusable and Disposable), End User (Hospital and Clinic), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2027. By: QualiKet Research Read More Info:https://lnkd.in/dtHGeaNM Key Players: Arthrex, BKK B. Braun Melsungen AG , CONMED Corporation, GPC Medical Ltd., Johnson & Johnson, Medtronic Plc, Portescap., SHARMA ORTHOPEDIC, Stryker, and Zimmer Biomet US 2 Holding Inc . #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market